Lasers News

Syneron Medical reported its strongest quarter ever with a 2014 fourth-quarter revenue of $74.1 million, up 23.7% compared with $59.9 million in the fourth quarter of 2013 on a pro-forma basis.

Syneron Medical has appointed William Griffing to the newly created position of CEO of Syneron Candela North America as part of an enhanced leadership team.

In a comparison of photographs, researchers determined facial aesthetic unit separation influenced the perceived youthfulness of women, even among naïve observers.

Cynosure reported financial results for its fourth quarter and 12 months ending Dec. 31, 2014, with fourth quarter revenue up 16% year-over-year to $86.3 million and full-year 2014 revenue of $292.4 million, up 29%.

Results of a study on Mohs micrographic surgery-related lawsuits was the most-read article during the past week in Healio.com/Dermatology.

Healio.com/aesthetics has highlighted four of this week’s top stories in the area of facial rejuvenation, with topics ranging from the assessment of the impact upper facial lines has on patients to special surgical techniques used when performing facelifts in the Asian population.

Lumenis has announced the launch of its new ResurFX laser system for fractional, nonablative skin-resurfacing treatments.

Sebacia has announced positive results from two European clinical studies investigating the use of the company’s microparticles in combination with lasers for the treatment of acne.

Patients who underwent tattoo removal had a significant decrease in bulla formation in treatment of fractionated CO2 ablation combined with picosecond Alexandrite laser compared with picosecond laser treatment alone, according to recently published study results.

According to the results of an annual survey by the American Academy of Facial and Plastic Reconstructive Surgery, 13% of facial plastic surgeons surveyed saw an increase in requests for celebrity procedures in 2014, up from 3% in 2013 and 7% in 2012, according to a press release.